Justpoint Raises $95M to Combat Toxic Exposure with AI

Deal News | Feb 12, 2025 | Signalfire Management Services

Justpoint Raises $95M to Combat Toxic Exposure with AI

SignalFire is leading a $45 million Series A funding round for Justpoint, a company using AI to identify and litigate against harmful substances in consumer products and pharmaceuticals. Justpoint aims to address the crisis of toxic exposures that contribute to a significant percentage of cancer, heart attacks, and liver damage in the U.S. The company has developed advanced AI models to analyze vast amounts of data and identify potentially harmful substances faster than traditional regulatory methods. Justpoint’s efforts are motivated by personal experiences, particularly those of CEO Victor Bornstein, and include a focus on consumer safety through litigation and financial incentives for companies to enhance product safety. The initiative also includes a $50 million credit line, bringing the total funding to $95 million. The funding will enable Justpoint to scale its operations and extend its capabilities in consumer protection.

Sectors

  • Healthtech
  • Legaltech
  • Private Equity/Venture Capital

Geography

  • United States – The article discusses the toxic exposure epidemic in the U.S., and Justpoint's operations focus on addressing this issue within the country.

Industry

  • Healthtech – Justpoint leverages technology and AI to innovate within the health sector by identifying hazardous chemicals and fostering consumer safety.
  • Legaltech – The company's integration of AI in legal proceedings, aiming to initiate litigation against detrimental products, positions it within the legal technology sphere.
  • Private Equity/Venture Capital – SignalFire's investment in Justpoint indicates the involvement of private equity and venture capital sectors in financing innovative startups.

Financials

  • $95M – Total funding received by Justpoint, including $45M Series A and $50M from a credit line.

Participants

NameRoleTypeDescription
JustpointTarget companyCompanyA company using AI to detect harmful chemicals and pharmaceuticals, aiming to protect consumer safety through early warning and legal action.
SignalFireLead investorCompanyA private equity firm leading the Series A round of funding for Justpoint.
Victor BornsteinCEO and Co-founderPersonCEO of Justpoint, with a background in biomedical sciences and a personal connection to the mission due to familial experiences with toxic exposure.
Sashko ZakharchukCTO and Co-founderPersonCTO of Justpoint, with expertise in AI models, contributing significantly to the company's advanced technical capabilities.
Lauren MillerVP of LitigationPersonVP of Litigation at Justpoint, with significant experience in mass tort litigation and legal expertise to support consumer protection efforts.